We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Silicon Microparticles Boost Effectives of Potential Breast Cancer Vaccines

By LabMedica International staff writers
Posted on 19 May 2015
Print article
Image: The porous silicon microparticles are about one micrometer in diameter. The hollow channels within each microparticle can be loaded with antigens—such as HER2—that can help train the immune system to recognize and destroy cancer cells overexpressing HER2 (Photo courtesy of Dr. Haifa Shen\'s laboratory, Houston Methodist Research Institute).
Image: The porous silicon microparticles are about one micrometer in diameter. The hollow channels within each microparticle can be loaded with antigens—such as HER2—that can help train the immune system to recognize and destroy cancer cells overexpressing HER2 (Photo courtesy of Dr. Haifa Shen\'s laboratory, Houston Methodist Research Institute).
Microparticles constructed from porous silicon were found to increase the effectiveness of potential anti-breast-cancer vaccines by stimulating a type I interferon response even when not carrying any specific antigen.

Investigators at Houston Methodist Research Institute (Texas, USA) were interested in improving the performance of vaccines targeting the breast cancer HER2 oncoprotein. These vaccines have mostly not been very potent because of inefficient vaccine delivery, a poor immune response at the site of the tumor, and other factors.

In a study published in the April 30, 2015, online edition of the journal Cell Reports, the authors described the use of porous silicon microparticles (PSM) as delivery vehicles for anti-HER2 vaccines. They reported that a PSM-based cancer vaccine displayed greatly enhanced cross-presentation and activated type I interferon (IFN-I) response in dendritic cells. PSM-loaded antigen exhibited prolonged early endosome localization and enhanced cross-presentation through both proteasome- and lysosome-dependent pathways. Dendritic cells primed with PSM-loaded HER2 antigen produced robust CD8 T-cell-dependent anti-tumor immunity in mice bearing HER2+ mammary gland tumors.

"We have shown for the first time that a microparticle can serve as a carrier for sustained release and processing of tumor antigens," said senior author Dr. Haifa Shen, professor of nanomedicine at Houston Methodist Research Institute. "But just as importantly, we learned the microparticles themselves appear to be enough to stimulate a type I interferon response, and were even transferred from one antigen-presenting cell to another to maintain a long-lasting antigen-releasing effect. PSMs persistently challenge the antigen-presenting cells to activate the T-cells, and the PSMs modify the tumor microenvironment so that the cytotoxic T-cells maintain their activity."

"We could completely inhibit tumor growth after just one dose of the cancer vaccine in the animal model," said Dr. Shen. "This is the most amazing result we have ever seen in a tumor treatment study."

Related Links:

Houston Methodist Research Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.